Pharmacopsychiatry 2003; 36 - 318
DOI: 10.1055/s-2003-825561

Polish version of Medication Adherence Rating Scale (MARS)

A Wolźniak 1, T Szafrański 1
  • 1III Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland

The aim of our study was to examine the properties of the polish language version of MARS – new compliance scale constructed with the aim of greater validity and clinical utility*.

60 schizophrenia inpatients treated with neuroleptics were assessed with MARS, DAI-10, UKU and PANSS. Patients were divided into two groups – those with MARS total score <7 were classified as non-compliant. There were no differences between two groups in terms of age, education, duration of illness, number of hospitalizations. Non -compliant group had higher score on uncooperativenes (G8) and lack of insight (G12) items on PANSS (3.59±1.24 vs. 2.57±1.17 and 4.96±1.34 vs. 3.87±1.21 respectively; p<0.002), and lower DAI-10 scores (13.9±2.4 vs. 16.8±2.4; p<0.0001). MARS total score correlated negatively with excitement factor of PANSS (r=–0.39, p=0.002).

References:

* Thompson K., Kulkarni J., Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for psychosis. Schizophr Res 2000, 5; 42: 241–247